cushieblog.com
MEKT1 Could Be a Potential New Therapy for Treating Cushing’s Disease
MEKT1, a type of therapy called a PPAR-γ agonist, acts to reduce levels of the adrenocorticotropic hormone and could be a potential new therapy for Cushing’s disease, according to researchers. Thei…